课题基金 / 基金详情

Genistein and Asthma Pathogenesis

Genistein and Asthma Pathogenesis
金雀异黄素和哮喘发病机制
批准号:
7110562
负责人:
RAVI KALHAN
金额:
$6.38万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-07-01 至 2007-06-30

项目摘要

项目成果

RAVI KALHAN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Airway remodeling in asthma results in irreversible airflow obstruction. Genistein is a dietary isoflavone and tyrosine kinase inhibitor found in soy. An epidemiologic study revealed that subjects with asthma having higher genistein intake have less airflow obstruction. In animal asthma models, genistein reduces bronchoconstriction, lung leukotriene levels, and airway eosinophilia. We found that genistein impairs eosinophil leukotriene synthesis and inhibits the transformation of fibroblasts to myofibroblasts, a key phenotypic change of the remodeled airway. We hypothesize that genistein blocks the transformation of lung fibroblasts to myofibroblasts by inhibiting TGF-beta1- and integrin-induced intracellular signaling. We test genistein's ability to inhibit TGF-beta1 stimulated activation of Smad-transcription factors, p38, and JNK. We evaluate genistein's effects on TGF-beta1- and integrin-stimulated activation of focal adhesion kinase (FAK) and src, and the downstream consequences of blocking FAK and src on JNK and p38. Exploring these mechanisms will expand the scientific rationale for tyrosine kinase inhibition as a therapeutic approach to asthmatic airway remodeling, and justify further study of the therapeutic role of soy isoflavones.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Transitions from Impaired Respiratory Health to Lung Disease
Diversity Supplement to the Transitions from Impaired Respiratory Health to Lung Disease
Transitions from Impaired Respiratory Health to Lung Disease
Transitions from Impaired Respiratory Health to Lung Disease
国内基金
海外基金
大鱼际掌纹特应征与5个哮喘易感基因单核苷酸多态性的关联分析
  • 批准号:
    30873315
  • 项目类别:
    面上项目
  • 资助金额:
    31.0万元
  • 批准年份:
    2008
  • 负责人:
    周兆山
  • 依托单位:
调节性T细胞和共刺激分子在过敏原早期暴露诱导哮喘免疫耐受中的作用机制研究
  • 批准号:
    30740048
  • 项目类别:
    专项基金项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2007
  • 负责人:
    李海潮
  • 依托单位:
CBP介导STAT4/STAT6相互拮抗在哮喘Th失衡中的机制
  • 批准号:
    30672268
  • 项目类别:
    面上项目
  • 资助金额:
    28.0万元
  • 批准年份:
    2006
  • 负责人:
    符州
  • 依托单位: